Regorafenib Inhibits Tumor Progression Through Suppression of ERK/NF-κB Activation in Hepatocellular Carcinoma Bearing Mice
Bioscience Reports - Netherlands
doi 10.1042/bsr20171264
Full Text
Open PDFAbstract
Available in full text
Date
May 8, 2018
Authors
Publisher
Portland Press Ltd.